Skip to main content
OpenTrials

Clinical trial condition

Opportunistic Infections

Explore clinical trials studying Opportunistic Infections. Study availability and eligibility vary by location and protocol.

155 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Opportunistic Infections trial results

Completed

A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis

NCT00002187

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +22 more
Locations
  • Retina - Vitreous Associates Med Group Los Angeles, California, United States
  • Community Eye Med Group Pasadena, California, United States
  • Univ of California San Francisco / SF Gen Hosp San Francisco, California, United States
  • Dr Jacob Lalezari San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Safety and Effectiveness of Topotecan HCl to Treat HIV-Infected Patients With AIDS-Related Progressive Multifocal Leukoencephalopathy (PML)

NCT00002395

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Brain Diseases, +28 more
Locations
  • Veteran's Administration Hosp / West LA Los Angeles, California, United States
  • HIV Institute / Davies Med Ctr San Francisco, California, United States
  • Univ of Miami Miami, Florida, United States
  • Johns Hopkins Univ Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

NCT00002169

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +22 more
Locations
  • Univ of Southern California / LA County USC Med Cntr Los Angeles, California, United States
  • Univ of California / UCI Med Ctr Orange, California, United States
  • Univ of California / San Diego Treatment Ctr San Diego, California, United States
  • Harbor UCLA Med Ctr Torrance, California, United States
View Trial Details
Completed

Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)

NCT00002186

Conditions
AIDS-Related Opportunistic Infections, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Sorra Research Ctr Inc / Med Forum Birmingham, Alabama, United States
  • Hill Top Research Ltd Scottsdale, Arizona, United States
  • Arizona Clinical Research Ctr Inc Tucson, Arizona, United States
  • Dermatology SVC - VAMC Long Beach, California, United States
View all 34 locations
View Trial Details

Related conditions